117 related articles for article (PubMed ID: 16531262)
21. Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy.
Yanada M; Sugiura I; Takeuchi J; Akiyama H; Maruta A; Ueda Y; Usui N; Yagasaki F; Yujiri T; Takeuchi M; Nishii K; Kimura Y; Miyawaki S; Narimatsu H; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
Br J Haematol; 2008 Nov; 143(4):503-10. PubMed ID: 18986386
[TBL] [Abstract][Full Text] [Related]
22. Late appearance of Philadelphia chromosome with the p190 BCR/ABL chimeric transcript in acute myelogenous leukemia progressing from myelodysplastic syndrome.
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Murakami N; Miura O
Rinsho Ketsueki; 2003 Apr; 44(4):242-8. PubMed ID: 12784657
[TBL] [Abstract][Full Text] [Related]
23. Transient pancytopenia preceding acute lymphoblastic leukemia with positive Philadelphia chromosome.
Li Q; Chen Z; You Y; Zou P
Leuk Res; 2008 Aug; 32(8):1317-20. PubMed ID: 18291524
[TBL] [Abstract][Full Text] [Related]
24. Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.
Storring JM; Minden MD; Kao S; Gupta V; Schuh AC; Schimmer AD; Yee KW; Kamel-Reid S; Chang H; Lipton JH; Messner HA; Xu W; Brandwein JM
Br J Haematol; 2009 Jun; 146(1):76-85. PubMed ID: 19438471
[TBL] [Abstract][Full Text] [Related]
25. Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases.
Miglino M; Varaldo R; Colombo N; Grasso R; Clavio M; Garuti A; Aquino S; Albarello A; Sessarego M; Gobbi M
J Exp Clin Cancer Res; 2006 Sep; 25(3):321-4. PubMed ID: 17167971
[TBL] [Abstract][Full Text] [Related]
26. 9q34 rearrangements in BCR/ABL fusion-negative acute lymphoblastic leukemia.
Dave BJ; Wiggins M; Higgins CM; Pickering DL; Perry D; Aoun P; Abromowich M; DeVetten M; Sanger WG
Cancer Genet Cytogenet; 2005 Oct; 162(1):30-7. PubMed ID: 16157197
[TBL] [Abstract][Full Text] [Related]
27. A multicenter total therapy strategy for
Chiaretti S; Ansuinelli M; Vitale A; Elia L; Matarazzo M; Piciocchi A; Fazi P; Di Raimondo F; Santoro L; Fabbiano F; Califano C; Martinelli G; Ronco F; Ferrara F; Cascavilla N; Bigazzi C; Tedeschi A; Sica S; Di Renzo N; Melpignano A; Beltrami G; Vignetti M; Foa R
Haematologica; 2021 Jul; 106(7):1828-1838. PubMed ID: 33538150
[TBL] [Abstract][Full Text] [Related]
28. Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia.
Grammatico S; Elia L; Peluso AL; Pedace L; Matarazzo M; Vitale A; Rago A; Pane F; Foà R; Cimino G
Leuk Res; 2009 Jul; 33(7):e73-4. PubMed ID: 19108887
[No Abstract] [Full Text] [Related]
29. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
[TBL] [Abstract][Full Text] [Related]
31. Proportion of long-term event-free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic program: adult acute lymphoblastic leukemia-94 trial.
Le QH; Thomas X; Ecochard R; Iwaz J; Lhéritier V; Michallet M; Fiere D
Cancer; 2007 May; 109(10):2058-67. PubMed ID: 17407135
[TBL] [Abstract][Full Text] [Related]
32. [Philadelphia chromosome-positive acute lymphoblastic leukemia showing normal karyotype at presentation].
Maki K; Nakamura F; Gunji H; Arai Y; Mitani K
Rinsho Ketsueki; 2003 Nov; 44(11):1110-2. PubMed ID: 14689877
[TBL] [Abstract][Full Text] [Related]
33. Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage.
Järås M; Johnels P; Agerstam H; Lassen C; Rissler M; Edén P; Cammenga J; Olofsson T; Bjerrum OW; Richter J; Fan X; Fioretos T
Exp Hematol; 2009 Mar; 37(3):367-75. PubMed ID: 19135771
[TBL] [Abstract][Full Text] [Related]
34. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
Yi SJ; Lee HT; Groffen J; Heisterkamp N
Int J Mol Med; 2008 Oct; 22(4):453-8. PubMed ID: 18813851
[TBL] [Abstract][Full Text] [Related]
35. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
Hunault M; Truchan-Graczyk M; Caillot D; Harousseau JL; Bologna S; Himberlin C; Guyotat D; Berthou C; Casassus P; Baranger L; Béné MC; Ifrah N; Gyan E;
Haematologica; 2007 Dec; 92(12):1623-30. PubMed ID: 18055985
[TBL] [Abstract][Full Text] [Related]
36. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
Huguet F; Leguay T; Raffoux E; Thomas X; Beldjord K; Delabesse E; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Lafage-Pochitaloff M; Chassevent A; Lhéritier V; Macintyre E; Béné MC; Ifrah N; Dombret H
J Clin Oncol; 2009 Feb; 27(6):911-8. PubMed ID: 19124805
[TBL] [Abstract][Full Text] [Related]
37. A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response.
Press RD; Galderisi C; Yang R; Rempfer C; Willis SG; Mauro MJ; Druker BJ; Deininger MW
Clin Cancer Res; 2007 Oct; 13(20):6136-43. PubMed ID: 17947479
[TBL] [Abstract][Full Text] [Related]
38. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
39. [Major molecular response to imatinib in a patient with acute mixed lineage leukemia expressing a novel BCR/ABL transcript].
Liu HX; Cao XY; Tong CR; Wu T; Wang T; Fan QZ; Wu P; Zhang X; Cai P; Zhu P
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):220-3. PubMed ID: 19552835
[TBL] [Abstract][Full Text] [Related]
40. Methodologic and biological variability of quantitative real-time polymerase chain reaction analysis of Bcr-Abl expression in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Scheuring UJ; Pfeifer H; Wassmann B; Brück P; Hoelzer D; Ottmann OG
Haematologica; 2003 Sep; 88(9):1074-6. PubMed ID: 12969819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
